Patent 7148024 was granted and assigned to Saladax Biomedical on December, 2006 by the United States Patent and Trademark Office.
Novel conjugates of busulfan and novel busulfan immunogens derived from α-substituted derivatives of busulfan and antibodies generated by these busulfan linked immunogens are useful in immunoassays for the quantification and monitoring of busulfan in biological fluids.